Expression of ErbB2 and ErbB3 in resected non- small cell lung cancer (NSCLC) patients (pts)

被引：1
|
作者：
Felip, E.
Salcedo, M.
Murtra-Garrell, N.
Navarro, A.
Teixido, C.
Hernandez-Losa, J.
Cedres, S.
Martinez, P.
Lopez, E.
Montero, M. A.
Freixinos, V.
Argiles, G.
Nunez, I.
Peg, V.
Pallisa, E.
Canela, M.
Tabernero, J.
Ramon y Cajal, S.
Tallada, N.
机构：
[1] Vall dHebron Univ Hosp, Barcelona, Spain
[2] Vall dHebron Univ Hosp, Dept Pathol, Barcelona, Spain
[3] Vall dHebron Univ Hosp, Dept Stat, Barcelona, Spain
[4] Vall dHebron Univ Hosp, Dept Radiol, Barcelona, Spain
[5] Vall dHebron Univ Hosp, Dept Thorac Surg, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.7037
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7037
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Expression of receptors for neuregulins, ErbB2, ErbB3 and ErbB4, in developing mouse cerebellum
    Ozaki, M
    Kishigami, S
    Yano, R
    NEUROSCIENCE RESEARCH, 1998, 30 (04) : 351 - 354
  • [22] SON is an essential RNA splicing factor promoting ErbB2 and ErbB3 expression in breast cancer
    Phillips, Joshua B.
    Park, Seong-Sik
    Lin, Cheng-Han
    Cho, Juyoung
    Lim, Sangbin
    Aurora, Ritu
    Kim, Jin-Hwan
    Angajala, Anusha
    Park, Bohye
    Stone, Joshua K.
    Wang, Bin
    Kahn, Andrea G.
    Lim, Ssang-Taek Steve
    Kim, Jung-Hyun
    Ahn, Eun-Young Erin
    Tan, Ming
    BRITISH JOURNAL OF CANCER, 2024, 131 (09) : 1437 - 1449
  • [23] Hirschsprung disease and more: dysregulation of ERBB2 and ERBB3
    Gershon, Michael D.
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (06):
  • [24] Infrequent ERBB2 mutations in Chinese patients with non-small cell lung cancer
    Feng, Shuidong
    Ling, Hongyan
    Guo, Hui
    Tong, Lingling
    Hu, Guobin
    Liao, Li
    Lv, Xueying
    Tan, Hongzhuan
    Wu, Yimou
    JOURNAL OF THORACIC DISEASE, 2014, 6 (05) : 503 - 506
  • [25] Expression of heregulin α, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells
    Noguchi, H
    Sakamoto, C
    Wada, K
    Akamatsu, T
    Uchida, T
    Tatsuguchi, A
    Matsui, H
    Fukui, H
    Fujimori, T
    Kasuga, M
    GASTROENTEROLOGY, 1999, 117 (05) : 1119 - 1127
  • [26] Enhancement of erbB2 and erbB3 expression during oral oncogenesis in diabetic rats
    Eleftherios Vairaktaris
    Lambros Goutzanis
    Stavros Vassiliou
    Sofia Spyridonidou
    Emeka Nkenke
    Georgios Papageorgiou
    Pashalis Strantzias
    Andreas Lazaris
    Christos Yapijakis
    Efstratios Patsouris
    Journal of Cancer Research and Clinical Oncology, 2008, 134 : 337 - 344
  • [27] Enhancement of erbB2 and erbB3 expression during oral oncogenesis in diabetic rats
    Vairaktaris, Eleftherios
    Goutzanis, Lambros
    Vassiliou, Stavros
    Spyridonidou, Sofia
    Nkenke, Emeka
    Papageorgiou, Georgios
    Strantzias, Pashalis
    Lazaris, Andreas
    Yapijakis, Christos
    Patsouris, Efstratios
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (03) : 337 - 344
  • [28] The ErbB3/4 receptor ligand Heregulin negatively regulates ErbB2 and ErbB3 receptor levels
    Awasthi, Smita
    Ghosh, Arundhati
    Wilson, Gerald M.
    Hassel, Bret A.
    Hamburger, Anne W.
    CANCER RESEARCH, 2012, 72
  • [29] Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers
    Maegawa, Mari
    Takeuchi, Kenji
    Funakoshi, Eishi
    Kawasaki, Katsumi
    Nishio, Kazuto
    Shimizu, Nobuyoshi
    Ito, Fumiaki
    MOLECULAR CANCER RESEARCH, 2007, 5 (04) : 393 - 401
  • [30] C-erbB-3 Expression in Non-small Cell Lung Cancer (NSCLC) Patients Treated by Erlotinib
    Cstoth, Ingrid
    Anthoine, Geraldine
    Berghmans, Thierry
    Mascaux, Celine
    Paesmans, Marianne
    Sculier, Jean-Paul
    Meert, Anne-Pascale
    ANTICANCER RESEARCH, 2011, 31 (01) : 281 - 285
12345